The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000138.5(FBN1):c.188A>G (p.Tyr63Cys)

CA392448489

547296 (ClinVar)

Gene: FBN1
Condition: Marfan syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: b84cf0fd-d40e-4407-96af-74368d614b6e
Approved on: 2023-12-21
Published on: 2023-12-21

HGVS expressions

NM_000138.5:c.188A>G
NM_000138.5(FBN1):c.188A>G (p.Tyr63Cys)
NC_000015.10:g.48613069T>C
CM000677.2:g.48613069T>C
NC_000015.9:g.48905266T>C
CM000677.1:g.48905266T>C
NC_000015.8:g.46692558T>C
NG_008805.2:g.37720A>G
ENST00000316623.10:c.188A>G
ENST00000316623.9:c.188A>G
ENST00000537463.6:c.188A>G
NM_000138.4:c.188A>G
More

Uncertain Significance

Met criteria codes 3
PS4_Moderate PP4 PP2
Not Met criteria codes 3
PP3 PM2 PM1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
FBN1 VCEP
The NM_00138 c.188A>G is a missense variant in FBN1 predicted to cause a substitution of a tyrosine by cysteine at amino acid 63 (p.Tyr63Cys). This variant was found in a proband with a clinical diagnosis of Marfan syndrome (PMID 17657824) (PP4). This variant in FBN1 has been reported three times in ClinVar: 1 time as uncertain significance, 1 time as likely pathogenic, and 1 time as pathogenic (Variation ID: 547296). This variant has previously been reported in at least two apparently unrelated individuals with ectopia lentis (PMID 25053872, 28941062) and in an individual with a suspected or confimed diagnosis of Marfan syndrome (Centre for Human Genetics, Inc. ClinVar entry) (PS4_mod). This variant has been identified in 1/112420 (0.0004%) individuals of European non-Finnish origin (https://gnomad.broadinstitute.org/version 2.1.1). Computational prediction tools and conservation analysis are inconclusive data with regards to a possible impact on this variant protein function and structure (REVEL: 0.72). The constraint z-score for missense variants affecting FBN1 is 5.06 (PP2). Due to the conflicting evidence, this variant is classified as uncertain significance for Marfan syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen FBN1 VCEP: PS4_Mod, PP2, PP4
Met criteria codes
PS4_Moderate
2.5 Points
PP4
PMID: 17657824- Proband with ectopia lentis, minor skin and skeletal features
PP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Not Met criteria codes
PP3
REVEL score: 0.702 (threshold: >0.75)
PM2
Present in 1/249416 (0.0004%) alleles in gnomAD, including in 1/112420 (0.0009%) of European (non-Finnish) alleles of gnomAD 2.1.1; Absent in gnomAD v.4.0.0
PM1
Cys-creating variant not in a critical domain
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.